Aakaar Medical Technologies Ltd vs Clinitech Laboratory Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Aakaar Medical Technologies Ltd is ₹ 71.4 as of 16 Jun 15:30 . The P/E Ratio of Aakaar Medical Technologies Ltd is 0 as of March 2025 .The P/E Ratio of Clinitech Laboratory Ltd is 23.3 as of March 2025 . The Market Cap of Aakaar Medical Technologies Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Clinitech Laboratory Ltd is ₹ 9.18 crore as of March 2025 . The Dividend Payout of Aakaar Medical Technologies Ltd changed from 34.57 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aakaar Medical Technologies Ltd

Aakaar Medical Technologies Limited was originally incorporated as Aakaar Medical Technologies Private Limited', a private limited company dated June 20, 2013 issued by the Registrar of Companies, Mumbai.
Subsequently, Company status was converted into a public limited company and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of Company to Aakaar Medical Technologies Limited'. Incorporated in 2013, Aakaar Medicals are a medical aesthetic company dealing in a wide range of aesthetics & specialised cosmetic products & devices.
The Company supply its products & devices primarily to aesthetic physicians such as dermatologists, plastic surgeons, aesthetic physicians who sell these products to end consumers as well as use certain device consumables as part of their treatments.

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.
Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.

FAQs for the comparison of Aakaar Medical Technologies Ltd and Clinitech Laboratory Ltd

Which company has a larger market capitalization, Aakaar Medical Technologies Ltd or Clinitech Laboratory Ltd?

Market cap of Aakaar Medical Technologies Ltd is 90 Cr while Market cap of Clinitech Laboratory Ltd is 7 Cr

What are the key factors driving the stock performance of Aakaar Medical Technologies Ltd and Clinitech Laboratory Ltd?

The stock performance of Aakaar Medical Technologies Ltd and Clinitech Laboratory Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aakaar Medical Technologies Ltd and Clinitech Laboratory Ltd?

As of October 25, 2026, the Aakaar Medical Technologies Ltd stock price is INR ₹63.8. On the other hand, Clinitech Laboratory Ltd stock price is INR ₹32.0.

How do dividend payouts of Aakaar Medical Technologies Ltd and Clinitech Laboratory Ltd compare?

To compare the dividend payouts of Aakaar Medical Technologies Ltd and Clinitech Laboratory Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.